According to the results of a new study in the New England Journal of Medicine, 92% of patients who took this drug were cancer-free after two years.

A new study found that the immunotherapy treatment worked against some types of cancers, allowing patients to avoid surgery ...

The results from an ambitious cancer study are giving hope that immunotherapy drugs alone can treat some gastrointestinal tumors, eliminating the need for severe, life-altering surgeries and other ...

Some people with early stage cancers may be able to skip surgery after being treated with the immunotherapy drug dostarlimab, ...

A New England Journal of Medicine study published April 27 found success in administering dostarlimab, an immunotherapy drug, ...

I couldn't believe it worked that quick, to be honest," Knolmayer told CBS News.He's part of an immunotherapy study that ...

Seniors with cancer respond just as well as younger patients to immune checkpoint inhibitors immunotherapy treatment.

Newly discovered oncology drugs called “DNA-encoded tri-specific T-cell engagers,” or “DTriTEs,” engage the immune system ...

So far, the vaccine has been given to 600 dogs at 11 clinics across the U.S., including two in Washington state.

A new clinical trial shows the immunotherapy drug dostarlimab could eliminate the need for surgery and chemotherapy in certain cancers. The results are a medical breakthrough since the drug could ...

No more IV drips, cancer patients on immunotherapy can now take the drug in a single injection. The National Health Service ...

The trial participants were among the 2 to 3 percent of cancer patients with tumors that should respond to immunotherapy, a drug that overcomes barriers that prevent the immune system from ...